Every year, tens of thousands of people with signs of Parkinson's disease go unnoticed until the incurable neurodegenerative ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

Medication aside, there are many ways people living with Parkinson’s disease can improve their health and well-being, preserve physical function, ease symptoms and enhance quality of life. Chief among ...

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...

Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...

Roche is set to advance prasinezumab into phase III for early Parkinson's, ... RHHBY to Advance Parkinson's Disease Drug to Late-Stage Development June 16, 2025 — 09:49 am EDT.

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...